Unknown PHASE4 INTERVENTIONAL 1-arm NCT02593409

HIV PrEP Priming of Immune Effectors (PREPPIE)

HIV Pre-Exposure Prophylaxis Priming of Immune Effectors

Sponsor: MRC/UVRI and LSHTM Uganda Research Unit

Interventions TDF/FTC

Updated 8 times since 2017 Last updated: Sep 18, 2017 Started: May 25, 2017 Primary completion: Apr 30, 2018 Completion: Jun 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02593409, this PHASE4 trial focuses on HIV-1 Infections and remains ongoing. Sponsored by MRC/UVRI and LSHTM Uganda Research Unit, it has been updated 8 times since 2017, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2021 — Oct 2021 [monthly]

Unknown Status PHASE4
Oct 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Oct 2019 [monthly]

Recruiting PHASE4
Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting · Phase: NA → PHASE4
Jan 2017 — Oct 2017 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MRC/UVRI and LSHTM Uganda Research Unit

Data source: MRC/UVRI and LSHTM Uganda Research Unit

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kampala, Uganda